One in five: why the UK pharma industry is going to court over spending caps

The ABPI is taking UK drug regulator NICE to court over new spending caps, which will affect one in five of all new approved drugs. Abi Millar looks into the issues surrounding this important legal contest.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news